Evidence map›Paper›PMID 36839368›Full record

Trial reportNutrients2023

Low-Protein Formulas with Alpha-Lactalbumin-Enriched or Glycomacropeptide-Reduced Whey: Effects on Growth, Nutrient Intake and Protein Metabolism during Early Infancy: A Randomized, Double-Blinded Controlled Trial.

Ulrika Tinghäll Nilsson, Olle Hernell, Bo Lönnerdal, Merete Lindberg Hartvigsen, Lotte Neergaard Jacobsen, Anne Staudt Kvistgaard, Pia Karlsland Åkeson

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. A Systematic Review to Reassess the Formula for Early Life Growth.Advances in nutrition (Bethesda, Md.) · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Human milkFrontiers in nutrition · 2025
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Ulrika Tinghäll NilssonDepartment of Clinical Sciences, Pediatrics, Lund University, 221 00 Lund, Sweden.
Olle HernellDepartment of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, Sweden.
Bo LönnerdalDepartment of Nutrition, University of California, Davis, CA 95616, USA.ORCID 0000-0002-3459-2484
Merete Lindberg HartvigsenArla Foods Ingredients Group P/S, 8260 Viby J, Denmark.
Lotte Neergaard JacobsenArla Foods Ingredients Group P/S, 8260 Viby J, Denmark.
Anne Staudt KvistgaardArla Foods Ingredients Group P/S, 8260 Viby J, Denmark.
Pia Karlsland ÅkesonDepartment of Clinical Sciences, Pediatrics, Lund University, 221 00 Lund, Sweden.
Arla Foods (Denmark) · DKLund University · SEUmeå University · SEUniversity of California, Davis · US

Funding

Arla Foods Ingredients Arla Foods Ingredients grant
6 · The paper itself

Abstract

Protein intake is higher in formula-fed than in breast-fed infants during infancy, which may lead to an increased risk of being overweight. Applying alpha-lactalbumin (α-lac)-enriched whey or casein glycomacropeptide (CGMP)-reduced whey to infant formula may enable further reduction of formula protein by improving the amino acid profile. Growth, nutrient intake, and protein metabolites were evaluated in a randomized, prospective, double-blinded intervention trial where term infants received standard formula (SF:2.2 g protein/100 kcal;

Indexed as

CaseinsLactalbuminEatingHumansInfantInfant FormulaInfant Nutritional Physiological PhenomenaPeptide FragmentsProspective StudiesWeight GainWheyWhey ProteinscaseinomacropeptideCaseinsLactalbuminPeptide FragmentsWhey Proteinsalpha-lactalbuminamino acidsCGMPenergetic efficiencyinfant formulainfant growthlow proteinobesityprotein metabolismprotein quality

Identifiers

PMID36839368
PMCPMC9958764
OpenAlexW4321376234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.